TREAT-NMD (Translational Research in Europe, Assessment and Treatment for NeuroMuscular Disorders) is a global academic network that focuses on advancing research in neuromuscular disorders.
[1] It was established in 2007 with its coordination centre at the Newcastle University.
[4] The network's aim is to provide infrastructure to accelerating research through supporting collaboration between its members.
[5] Its main goals include improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research.
[6][7] Through patient registries, TREAT-NMD provides genotype–phenotype correlation between genetic mutations and neuromuscular disease burden.